It's interesting that Lena is already changing the dynamic of NRs. A co-release of the latest NR with DM clearly cements that connection ...at least as far as covid testing is concerned. Could there be another one soon conveying the positives from Q3.
As she puts her stamp on managing the company some interesting analyses are starting to evolve. Again today and for almost two weeks, Morningstar's Fair Value sp remains at $.05.
While Barchart will not offer a buy, hold or sell sentiment until there is 200 days of data to collect they do offer some insight into the sp. Not surprisingly the current sp actually sits below their analysis of the strongest level of support. While it's small fractions of a cent the point is this is impossible without manipulation.
The three resistance levels are smashed between $.03 and $.04. Someone doesn't want this stock to move.
The good news is that anything positive regarding revenues for Q3 should finally settle any debate about the valuation of ScreenPro. There are hundreds and hundreds of companies that come nowhere near the bottom line of ScreenPro ....and yet trade at levels 10x to 20x the sp of SCRN. Surely this can't go on forever.
GLTE!!!